How many institutions held DWTX - Dogwood Therapeutics, Inc. - Common Stock, $0.0001 par value in Q4 2024?

10 institutional investors reported DWTX - Dogwood Therapeutics, Inc. - Common Stock, $0.0001 par value for Q4 2024. Use the holders table for investor-level position and value details.

Dogwood Therapeutics, Inc. - Common Stock, $0.0001 par value (DWTX)

Q: What does CUSIP 92829J203 represent in this 13F holders report?

CUSIP 92829J203 is the security identifier for DWTX - Dogwood Therapeutics, Inc. - Common Stock, $0.0001 par value used to aggregate holder disclosures.

CUSIP: 92829J203

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class: Equity / Common Stock, $0.0001 par value
Shares outstanding: 29,716,833
Total 13F shares: 30,770
Share change: +30,762
Total reported value: $76,511
Price per share: $2.49
Number of holders: 10
Value change: +$76,491
Number of buys: 9

Quarterly Holders Quick Answers

What is CUSIP 92829J203?
CUSIP 92829J203 identifies DWTX - Dogwood Therapeutics, Inc. - Common Stock, $0.0001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2025

Recent filing periods for CUSIP 92829J203:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024

Top shareholders of DWTX - Dogwood Therapeutics, Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
William Pridgen	3/4/5	Director	— mixed-class rows	764,196 mixed-class rows	$992,479	—	26 Feb 2024	3/4/5
Richard Alan Burch	3/4/5	Director	— class O/S missing	2,917	—	—	26 Feb 2024	3/4/5

Institutional Holders of Dogwood Therapeutics, Inc. - Common Stock, $0.0001 par value (DWTX) as of Q4 2024

As of 31 Dec 2024, Dogwood Therapeutics, Inc. - Common Stock, $0.0001 par value (DWTX) was held by 10 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 30,770 shares. The largest 10 holders included UBS Group AG, GEODE CAPITAL MANAGEMENT, LLC, Tower Research Capital LLC (TRC), MORGAN STANLEY, NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO, Activest Wealth Management, GROUP ONE TRADING LLC, BlackRock, Inc., BANK OF AMERICA CORP /DE/, and SBI Securities Co., Ltd.. This page lists 10 institutional shareholders reporting positions in this security for the Q4 2024 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2024 vs Q4 2025 Across Filers

Q4 2025 holders

Q4 2024 holders

Holder diff

Investor	Q4 2025 Shares	Q4 2024 Shares	Share Diff	Share Chg %	Q4 2025 Value $	Q4 2024 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.